Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytoma, Malignant Fibrous × Observation × 1 year × Clear all

Sponsor

Conditions

Neoplasms 9 Prostatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Endometrial Neoplasms 7 Lung Neoplasms 6 Breast Neoplasms 6 Colorectal Neoplasms 5 Oropharyngeal Neoplasms 4 Stomach Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Mouth Neoplasms 3 Leukemia, Myeloid, Acute 3 Colonic Neoplasms 3 Urinary Bladder Neoplasms 2 Skin Neoplasms 2 Sarcoma 2 Pathologic Complete Response 2 Meningioma 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia 2 Leiomyoma 2 Esophageal Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Brain Neoplasms 2 Bone Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1

Interventions

pembrolizumab 4 Specimen Handling 3 Doxorubicin 3 Radiotherapy 2 Radiation 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 Biopsy 2 tremelimumab 1 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 olaratumab 1 futibatinib 1 fludarabine 1 eribulin 1 durvalumab 1 cabozantinib 1 avelumab 1 aldesleukin 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Quality of Life 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Histamine H2 Antagonists 1 Famotidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡